Literature DB >> 4025530

"Three cartilages" technique in intact canal wall tympanoplasty to prevent recurrent cholesteatoma.

E Chiossone.   

Abstract

Residual cholesteatoma is the consequence of leaving squamous epithelium in the mastoid and middle ear cleft. It has been demonstrated that the only effective way to reduce the risk of epidermoid cyst neoformation is meticulous and radical removal of cholesteatoma matrix and staging of the operation, regardless of whether a closed or open mastoid cavity tympanoplasty technique has been performed. Recurrent cholesteatoma usually occurs after intact canal wall tympanoplasty secondary to middle ear, attic, and mastoid retraction of the graft, especially in cases with destruction of the scutum or absence of malleus and incus; this is still considered a major problem with this surgical technique. During the last five years we have been performing a procedure we have developed to avoid this retraction. Concave autogenous cartilage from the upper part of the concha auriculae trimmed in three pieces to protect attic, mastoid, and middle ear for graft retraction has been successfully used in 106 surgical procedures. This study describes the surgical technique and analyzes the anatomic and hearing results.

Entities:  

Mesh:

Year:  1985        PMID: 4025530

Source DB:  PubMed          Journal:  Am J Otol        ISSN: 0192-9763


  3 in total

1.  Reconstruction of outer attic wall defects using bone paté: Long-term clinical and histological evaluation.

Authors:  Andrea Bacciu; Enrico Pasanisi; Vincenzo Vincenti; Filippo Di Lella; Salvatore Bacciu
Journal:  Eur Arch Otorhinolaryngol       Date:  2006-06-28       Impact factor: 2.503

Review 2.  Cholesteatoma: skin in the wrong place.

Authors:  J M Robinson
Journal:  J R Soc Med       Date:  1997-02       Impact factor: 5.344

Review 3.  [Reconstruction of the tympanic membrane applying cartilage: indications, techniques and results].

Authors:  A Neumann; K Jahnke
Journal:  HNO       Date:  2005-06       Impact factor: 1.284

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.